Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Finland
Summary - Nirsvimab (Beyfortus 50 Mg And 100 Mg Injection, Solution, Pre-Filled Syringe) Acquisition For Rsv Season 2025-2026
Deadline - Jul 03, 2025
GT reference number - 111305585
Product classification - Pharmaceutical products
Address - Finland
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 111305585
Document Type - Tender Notices
Description - Description: Nirsovimab (Beyfortus 50 mg and 100 mg injection, solution, pre -filled syringe) acquisition of the recommendation of the Health Services Council (Palkko) (8.5.2025) for infantry synuteytial virus (RSV) period for less than 3 months For those at risk,- who were born before the week of pregnancy 29,- have a heart disease that requires repair,- have a severe immune deficiency and/or bronkopulmonal dysplasia (BDP) and have had some support treatment for the past 6 months,- having Down's syndrome- which were born in September - February at pregnancy weeks 29-36 + 6 or- who were born during pregnancy weeks 29-36 + 6 and have children in the family.Nirsvimab is a recombinant neutraliz
Gt Ref Id - 111305585
Deadline - Jul 03, 2025
Similar Tenders :
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
